Dec 21, 2020
Mehdi Maghsoodnia is the CEO of 1health, the leading testing as a service (TaaS) company. He is passionate about personalized healthcare and increasing access to testing in the U.S.
1health launched TaaS earlier this year by bringing to market the first FDA Emergency Use Authorized COVID-19 saliva test, in partnership with IBX (Previously RUCDR). Through these at-home saliva tests, 1health is responsible for the deployment of 1% of COVID-19 testing across the United States.
Instead of asking people to go get tested in laboratories that are often crowded and have delayed results, Mehdi is driving his businesses to bring affordable, simple testing to the people, wherever they are. 1health partners with hospital systems, telehealth companies, corporations and government agencies, school systems, consumer brands, as well as public health departments around the country. Through its lab network, centralized platform, and health partnerships, now more than seven million Americans have access to the 1health COVID-19 saliva test.
Mehdi is on the board of SpineZone and MedCorder, and previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. He is also an industry fellow at UC Berkeley, where he teaches innovation and entrepreneurship. He holds a Master’s of Science in EECS from Stanford, and a Bachelor of Science from UC Berkeley.
Sign up for The Weekly Grind, for actionable insights and stories from successful entrepreneurs delivered to your inbox once per week: https://www.justgogrind.com/newsletter/
Listen to all episodes of the Just Go Grind Podcast: https://www.justgogrind.com/podcast/
Follow Justin Gordon on Twitter: https://twitter.com/justingordon212
Follow Justin Gordon on Instagram: https://www.instagram.com/justingordon8/